Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

5(71.4%)

Phase 2

1(14.3%)

N/A

1(14.3%)

7Total

Phase 1(5)

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07269496Phase 1Completed

Study to Compare Bioavailability and Pharmacokinetics of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80 mg) Administered Intravenously in Healthy Volunteers

Role: collaborator

NCT05168683Phase 1Completed

Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets

Role: collaborator

NCT03510338Phase 1Completed

Pharmacoscintigraphic Study to Evaluate Two Sildenafil Products

Role: collaborator

NCT02714842Phase 1Completed

Delayed Release Diclofenac Sodium Formulation vs Voltaren®

Role: lead

NCT02487602Not ApplicableCompleted

A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects

Role: collaborator

NCT01991028Phase 2Completed

A Study to Investigate Lung Deposition of Radiolabelled OligoG

Role: lead

NCT02004301Phase 1Completed

A Study to Investigate Delayed-release Tablets

Role: lead

All 7 trials loaded